期刊文献+

氯氮平对长期住院精神分裂症患者糖代谢的影响 被引量:4

Effects of Clozapine on glucose metabolism in chronic schizophrenic inpatients
下载PDF
导出
摘要 目的调查氯氮平对长期住院的精神分裂症患者糖代谢的影响。方法根据空腹静脉和餐后2 h静脉血糖水平,对服用氯氮平的长期住院男性精神分裂症患者进行糖尿病及与糖尿病相关状态的诊断。结果 67例患者中20例患者有糖尿病(29.8%),16例有糖耐量减低(IGT)(23.9%),6例有空腹血糖损害(IFG)(9%),25例为血糖代谢正常者(37.3%)。根据氯氮平剂量、体质指数和服药时间的不同将患者各分成3组,3组间的糖代谢异常发生率差异无统计学意义。正常组、IFG组、IGT组以及糖尿病组患者在胆固醇水平、体质指数、氯氮平剂量、三酯甘油水平以及服药时间之间差异无统计学意义。在IFG组,体质指数与患者每天氯氮平服用剂量之间呈显著性正相关(r=0.889,P=0.019),而在IGT组,各临床资料之间无明显相关性。结论长期服用氯氮平对精神分裂症患者糖代谢有明显影响。 Objective To explore the glucose metabolism in chronic schizophrenic inpatients by Clozapine treatment.Methods Accordingto the blood glucose level of fasting and glucose level after food intake 2 hours,the patients were diagnosed diabetes mellitus,impaired fasting glucose(IFG) and impaired glucose tolerance(IGT).Results Among 67 schizophrenic patients,20 cases(29.8%) were diabetes mellitus,16 cases(23.9%) were IGT,6 cases(9%) were IFG and 25 cases(37.3%) were normal in glucose metabolism.The rates of glucose metabolic conditions were not different among the three different subgroups when the patients were divided into three subgroups basedon the duration of Clozapine treatment,dose of Clozapine,and body mass index(BMI).There were not different in the level of cholesterol and triglyceride,the BMI and dose of Clozapine among the different groups of glucose metabolic conditions.In IFG group,the BMI and dose of Clozapine were significantly positive correlation(r=0.889,P=0.019).Conclusion The effects of Clozapine on glucose metabolism in chronic schizophrenic inpatients were significantly obvious.
出处 《实用临床医药杂志》 CAS 2011年第11期54-56,共3页 Journal of Clinical Medicine in Practice
关键词 精神分裂症 氯氮平 空腹血糖损害 糖耐量减低 糖尿病 Clozapine schizophrenia impaired fasting glucose impaired glucose tolerance diabetes mellitus
  • 相关文献

参考文献17

  • 1Lean M E, Pajonk F G. Patients on atypical antipsychotic drugs: another high- risk group for type 2 diabetes[J]. Diabetes Care, 2003, 26(5): 1597.
  • 2陈灏珠.实用内科学[M].北京:人民卫生出版社,2002.1843.
  • 3Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment resistant schizophrenic. A double blind comparison with chlorprornazine[J].Arch Gen Psychiatry, 1988, 45 (9) : 789.
  • 4Gentile S. Longterm treatment with atypical antipsychotics andthe risk of weight gain[J]. Drug Saf, 2006, 29(4): 303.
  • 5Henderson D, Louie P, Koul P, et al. Modafinil - associated weight Ions in a clozapinetreated schizx3affective dimrder patient[J]. Ann Clin Psychiatry, 2005, 17(2) : 95.
  • 6Henderson DC, Cagliero E, Gray, et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five - year naturalistic study [J].Am J psychiatry, 2000, 157 (6) : 975.
  • 7Goethe J, Szarek B, Caley C, et al. Signs and symptoms associated with the metabolic syndrome in psychiatric inpatients receiving antipsychotics. A retrospective chart review[J]. J Clin Psychiatry, 2007, 68(1): 22.
  • 8奚巍.氯氮平治疗与糖耐量异常的相关性初探[J].四川精神卫生,2000,13(3):169-169. 被引量:10
  • 9刘燕,朱玉华,卢卫红,王文忠,高哲石.精神病人伴发糖尿病的资料分析[J].上海精神医学,2001,13(1):29-30. 被引量:40
  • 10郑一瑾,王高华,程自立,臧德馨,王惠玲,吕明春.氯氮平和利培酮对首发精神分裂症患者糖代谢影响的研究[J].中华精神科杂志,2003,36(4):207-210. 被引量:48

二级参考文献31

  • 1王从杰,孙静,张志珺.抗精神病药与2型糖尿病[J].临床精神医学杂志,2004,14(5):313-314. 被引量:18
  • 2[1]祝惠民,黄泳齐.内科学,第三版.人民卫生出版社,1998,386~395
  • 3[2]Baptista T. Body weight gain induced by antipsychotic drugs.Acta Psychiatr Scand, 1999, 100: 3
  • 4[4]Ober S K, Hudak R, Rusterholtz A. Hyperglycemia and olanzapine. Am J Psychiatry, 1999, 156 : 3
  • 5[5]Colli A, Cocciolo M, Francobandiera G, et al. Diabetic ketocidosis associated with clozapine treatment. Diabetes-Care, 1999, 21: 176~177
  • 6[6]Gelenberg A J. Weight gain, diabetes, and related adverse effects of antipsychotics. Biological therapies in psychiatry, 1999,22 : 42~44
  • 7[7]Melkersson K I, Hulting A L, Brismar K E. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses. J Clin Psychiatry, 1999, 60: 783~791
  • 8[10].Allison D B, Mentore J L, Heo M, et al. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry, 1999, 156 : 1686
  • 9[1]Dwyer DS,Bradley RJ,Kablinger AS,et a1.Glucose metabolism in relation to schizophrenia and antipsychotic drugtreatment¨].Ann Clin Psychiatry,2001,13:103.
  • 10[3]Wozniak KM,Linnolia M.Hyperglycemic properhes of serotonin receptor antagomsts[J].Life Sci,1991,49:101.

共引文献481

同被引文献54

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部